Relmada Therapeutics (RLMD) Earnings Analysis
Relmada Therapeutics (RLMD) next reports earnings on 2026-08-06, consensus EPS -0.21 USD. Last quarter (2026-03-19) it missed with EPS -0.27 USD vs -0.14 USD est (-92.9%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -4.50.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RLMD next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.21 USD |
| Revenue estimate | n/a |
RLMD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-19 | -0.27 USD | -0.14 USD | -92.9% | Miss |
| 2025-11-13 | -0.3 USD | -0.04 USD | -650% | Miss |
| 2025-05-12 | -0.58 USD | -0.31 USD | -87.1% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
RLMD valuation and analyst view
| Trailing P/E | -4.50 |
|---|---|
| Trailing EPS | -0.67991 USD |
| Price / book | 1.98 |
| Dividend yield | 0.00% |
| Market cap | 0.52B |
| Analyst consensus | Buy (5 buy / 2 hold / 1 sell) |
| Avg price target | 12 USD |
Related research pages
Frequently asked questions
When is Relmada Therapeutics (RLMD)'s next earnings date?
Relmada Therapeutics is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.21 USD.
Did RLMD beat earnings last quarter?
In its 2026-03-19 report, RLMD posted EPS of -0.27 USD versus a -0.14 USD estimate — a miss of 92.9%.
What is RLMD's earnings track record?
Over the last 3 reported quarters with consensus data, RLMD beat estimates 0 times (0%).
What is RLMD's current P/E ratio and EPS?
RLMD trades at a trailing P/E of -4.50 on trailing EPS of -0.679905081561086 USD.
What do analysts rate RLMD?
Analyst consensus is "Buy" across 8 ratings (0 strong buy, 5 buy, 2 hold, 1 sell, 0 strong sell). Average 12-month price target: 12 USD.